Showing results (991-1000 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|February 25, 2019
Bioequivalence for highly variable drugs: regulatory agreements, disagreements, and harmonizationLaszlo Endrenyi, Laszlo TothfalusiJournal of Pharmacokinetics and Pharmacodynamics|March 30, 2017
PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedsideCatharine C Bulik, Justin C Bader, Li Zhang, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 31, 2017
Age-structured population model of cell survivalWojciech Krzyzanski, Pawel Wiczling, Asfiha GebreJournal of Pharmacokinetics and Pharmacodynamics|February 23, 2017
Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatmentsRobert Andersson, Tobias Kroon, Joachim Almquist, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 17, 2017
The multistate tuberculosis pharmacometric model: a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse modelChunli Chen, Fatima Ortega, Joaquin Rullas, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 15, 2017
Nonlinear mixed-effects models for pharmacokinetic data analysis: assessment of the random-effects distributionReza DrikvandiJournal of Pharmacokinetics and Pharmacodynamics|August 22, 2019
A quantitative systems pharmacology model of colonic motility with applications in drug developmentRaibatak Das, Lucia Wille, Liming Zhang, et al.Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2008
How does obesity affect residence time dispersion and the shape of drug disposition curves? Thiopental as an exampleMichael WeissJournal of Pharmacokinetics and Pharmacodynamics|March 22, 2014
Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexateKayode Ogungbenro, Leon Aarons, Journal of Pharmacokinetics and Pharmacodynamics|January 30, 2017
Population pharmacokinetics and pharmacodynamics of IONIS-GCGRRx, an antisense oligonucleotide for type 2 diabetes mellitus: a red blood cell lifespan modelKenneth T Luu, Erin S Morgan, Sanjay Bhanot, et al.Pageof 107